Research programme: ion channel modulators - Dynogen

Drug Profile

Research programme: ion channel modulators - Dynogen

Alternative Names: Ion channel modulators research programme - Dynogen/Newron

Latest Information Update: 05 May 2008

Price : $50

At a glance

  • Originator Newron Pharmaceuticals
  • Developer Dynogen Pharmaceuticals
  • Class
  • Mechanism of Action Ion channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Gastrointestinal disorders; Genitourinary disorders

Most Recent Events

  • 05 May 2008 Discontinued - Preclinical for Gastrointestinal disorders in USA (unspecified route)
  • 05 May 2008 Discontinued - Preclinical for Genitourinary disorders in USA (unspecified route)
  • 12 Oct 2004 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top